Early detection of cardiovascular disease can be life-changing. Problem is, many methods identify cardiac disease only after it has progressed to later stages. High-sensitivity troponin screening uses a blood sample to detect elevated risk of cardiovascular disease, years before most other methods. In this conversation between our Wellness host, Dr. Peter Nord, Medcan’s chief medical officer, and Tricia Ravalico, (pictured above) Director, Global Scientific Leadership and Education at Abbott, we explore the development of the hs-Troponin test and describe why it is so innovative.